O

Outlook Therapeutics
D

OTLK

4.88000
USD
-0.06
(-1.21%)
Market Closed
Volume
17,171
EPS
-4
Div Yield
-
P/E
-1
Market Cap
115,439,504
OverviewSignalsIdeasNews
Related Instruments
    A
    ACAD
    -0.240
    (-1.41%)
    16.790 USD
    A
    ARWR
    -2.890
    (-13.49%)
    18.540 USD
    A
    AXSM
    -4.300
    (-4.41%)
    93.150 USD
    C
    CRVS
    -0.31000
    (-3.64%)
    8.21000 USD
    I
    IMMP
    -0.02000
    (-0.96%)
    2.06000 USD
    T
    TRVN
    -2.02000
    (-44.99%)
    2.47000 USD
    V
    VKTX
    -3.960
    (-7.39%)
    49.620 USD
    Z
    ZYNE
    0
    (0%)
    0.000000 USD
    More
News

Title: Outlook Therapeutics

Sector: Healthcare
Industry: Biotechnology
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.